Effect of topiramate on eating behaviours in Prader-Willi syndrome: TOPRADER double-blind randomised placebo-controlled study

Prader–Willi Syndrome (PWS) is a rare genetic syndrome leading to severe behavioural disorders and mild cognitive impairment. The objective of this double-blind randomised placebo-controlled trial was to study the efficacy and tolerance of topiramate on behavioural disorders in patients with PWS. Pa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Psychiatry
Autors principals: Consoli, Angèle, Çabal Berthoumieu, Sophie, Raffin, Marie, Thuilleaux, Denise, Poitou, Christine, Coupaye, Muriel, Pinto, Graziella, Lebbah, Said, Zahr, Noel, Tauber, Maïthé, Cohen, David, Bonnot, Olivier
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6828670/
https://ncbi.nlm.nih.gov/pubmed/31685813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41398-019-0597-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars